Home/Filings/4/0001088020-12-000028
4//SEC Filing

DERMA SCIENCES, INC. 4

Accession 0001088020-12-000028

CIK 0000892160operating

Filed

May 29, 8:00 PM ET

Accepted

May 30, 9:55 PM ET

Size

8.1 KB

Accession

0001088020-12-000028

Insider Transaction Report

Form 4
Period: 2012-05-27
KEIM RICHARD
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2012-05-27+2,50075,688 total(indirect: By Management Group)
  • Exercise/Conversion

    Restricted Stock Units

    2012-05-272,5000 total
    Exercise: $0.00From: 2012-05-27Exp: 2012-05-27Common Stock (2,500 underlying)
Footnotes (4)
  • [F1]Represents shares of the issuer's common stock received upon the vesting of 2,500 restricted stock units, previously granted pursuant to the issuer's restricted stock plan.
  • [F2]Upon vesting, the reporting person received the number of shares of the issuer's common stock equal to the number of restricted stock units previously granted, without the payment of further consideration.
  • [F3]Of the securities reported herein, 8,125 are held directly by Richard Keim and 67,563 are held by Kensington Partners L.P., Kensington Partners II L.P. and Bald Eagle Fund Ltd. Richard Keim is a Managing Director of Kensington Management Group, LLC and therefore may be deemed to share voting and investment power with respect to these securities. Mr. Keim disclaims beneficial ownership of these securities held by Kensington Partners L.P., Kensington Partners II L.P. and Bald Eagle Fund Ltd.
  • [F4]The restricted stock units were originally granted in consideration of the reporting person's services to the issuer and without payment of consideration.

Issuer

DERMA SCIENCES, INC.

CIK 0000892160

Entity typeoperating
IncorporatedPA

Related Parties

1
  • filerCIK 0000892160

Filing Metadata

Form type
4
Filed
May 29, 8:00 PM ET
Accepted
May 30, 9:55 PM ET
Size
8.1 KB